Related Experiment Video
Updated: Jan 8, 2026

05:45
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
8.3K
g-C3N4-based complexes for treating in vitro oral cancer cells
Byeong Jin Gu1, So-Young Park2, Wooil Kim3
1Department of Dental Materials, School of Dentistry, Pusan National University, Yangsan, Korea.
American Journal of Dentistry
|December 13, 2025
Summary
A novel graphitic carbon nitride (g-C₃N₄) quantum dot (QD) complex, PGC-Ce6, effectively destroyed over 83% of oral cancer cells in vitro. This promising photodynamic therapy agent shows potential for clinical tumor treatment.
Area of Science:
- Materials Science: Synthesis and characterization of novel nanomaterials.
- Biomedical Engineering: Photodynamic therapy and cancer treatment applications.
- Chemistry: Reactive oxygen species (ROS) generation and evaluation.
Background:
- Oral cancer poses a significant global health challenge, necessitating innovative therapeutic strategies.
- Photodynamic therapy (PDT) offers a targeted approach to cancer treatment, utilizing photosensitizers and light activation.
- Graphitic carbon nitride (g-C₃N₄) quantum dots (QDs) are emerging nanomaterials with potential biomedical applications.
Purpose of the Study:
- To synthesize and evaluate novel g-C₃N₄ quantum dot (QD) complexes for their efficacy in destroying oral cancer cells.
- To assess the in vitro performance of these complexes under hydrogen peroxide (H₂O₂) and laser irradiation conditions.
Main Methods:
- Synthesis of gCN complexes using polymers, melamine precursor, metal, and photosensitizers.
- In vitro cell viability assays on oral cancer and normal cells.
- Evaluation of ROS production via methylene blue (MB) degradation and RNO-ID assays.
- Measurement of oxygen generation under H₂O₂ and laser irradiation.
Main Results:
- The PGC-Ce6 complex demonstrated significant destruction of over 83% of in vitro oral cancer cells.
- High viability (approximately 88%) of normal cells was observed when not exposed to laser irradiation.
- PGC-Ce6 effectively degraded MB solution and showed decreased RNO-ID absorbance, indicating ROS generation.
Conclusions:
- The synthesized g-C₃N₄ complex, PGC-Ce6, exhibits potent in vitro anticancer activity against oral cancer cells.
- PGC-Ce6 shows considerable promise as a photosensitizer for laser-activated photodynamic therapy in clinical settings.
- Further research is warranted to fully explore the therapeutic potential of PGC-Ce6 for tumor treatment.

